semaglutide pil La FDA ha approvato la pillola Wegovy da 25 mg (semaglutide orale monodose giornaliera, Novo Nordisk) come prima pillola agonista del GLP-1 per la gestione del peso. La nuova indicazione è “ridurre Ozempic-like pill: Oral semaglutide can

Goals: They expressed a desire to reach a soft goal of 250 lbs, then reassess from there

Novo Nordisk sues Eli Lilly, alleging the company's GLP-1 ads are 'deliberately false' Novo Nordisk, maker of the popular medications Ozempic and Wegovy, filed a lawsuit Tuesday against the pharmaceutical company Eli Lilly, accusing it of making deceptive advertising claims about its weight-loss drug Zepbound

Semaglutide is not recommended during pregnancy due to limited safety data in this population

At $349 monthly, its within reach for many more households

For more detailed guidance on injection site selection and rotation, see our guide on where to inject retatrutide